CaMKII as a therapeutic target in cardiovascular disease

OE Reyes Gaido, LJ Nkashama… - Annual review of …, 2023 - annualreviews.org
CaMKII (the multifunctional Ca2+ and calmodulin-dependent protein kinase II) is a highly
validated signal for promoting a variety of common diseases, particularly in the …

Emerging antiarrhythmic drugs for atrial fibrillation

A Saljic, J Heijman, D Dobrev - International Journal of Molecular …, 2022 - mdpi.com
Atrial fibrillation (AF), the most common cardiac arrhythmia worldwide, is driven by complex
mechanisms that differ between subgroups of patients. This complexity is apparent from the …

Novel CaMKII-δ inhibitor hesperadin exerts dual functions to ameliorate cardiac ischemia/reperfusion injury and inhibit tumor growth

J Zhang, R Liang, K Wang, W Zhang, M Zhang, L **… - Circulation, 2022 - Am Heart Assoc
Background: Cardiac ischemia/reperfusion (I/R) injury has emerged as an important
therapeutic target for ischemic heart disease, the leading cause of morbidity and mortality …

[HTML][HTML] Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors

M Donniacuo, A De Angelis, M Telesca… - Pharmacological …, 2023 - Elsevier
Atrial fibrillation (AF) is the most frequent arrhythmia and is associated with substantial
morbidity and mortality. Pathophysiological aspects consist in the activation of pro-fibrotic …

Gene editing in common cardiovascular diseases

AM Lauerer, XM Caravia, LS Maier, F Chemello… - Pharmacology & …, 2024 - Elsevier
Cardiovascular diseases are the leading cause of morbidity and mortality worldwide,
highlighting the high socioeconomic impact. Current treatment strategies like compound …

Experimental drugs for supraventricular tachycardia: an analysis of early phase clinical trials

B Narasimhan, K Gandhi, E Moras, L Wu… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Supraventricular tachycardias (SVT) are a diverse group of commonly
encountered arrhythmias arising at or above the atrioventricular (AV) node. Conventional …

Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 base editing improves survival and cardiac function in heart failure in mice

S Lebek, XM Caravia, F Chemello, W Tan… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Cardiovascular diseases are the main cause of worldwide morbidity and
mortality, highlighting the need for new therapeutic strategies. Autophosphorylation and …

Loss of CASK accelerates heart failure development

J Mustroph, CM Sag, F Bähr, AL Schmidtmann… - Circulation …, 2021 - Am Heart Assoc
Rationale: Increased myocardial activity of CaMKII (Ca/calmodulin-dependent kinase II)
leads to heart failure and arrhythmias. In Drosophila neurons, interaction of CaMKII with …

CaMKII in regulation of cell death during myocardial reperfusion injury

Y Yang, K Jiang, X Liu, M Qin, Y **ang - Frontiers in Molecular …, 2021 - frontiersin.org
Cardiovascular disease is the leading cause of death worldwide. In spite of the mature
managements of myocardial infarction (MI), post-MI reperfusion (I/R) injury results in high …

CaMKII,'jack of all trades' in inflammation during cardiac ischemia/reperfusion injury

W Zhang, E Dong, J Zhang, Y Zhang - Journal of Molecular and Cellular …, 2023 - Elsevier
Myocardial infarction and revascularization cause cardiac ischemia/reperfusion (I/R) injury
featuring cardiomyocyte death and inflammation. The Ca 2+/calmodulin dependent protein …